A number of studies have demonstrated the stimulatory role elicited by S100A7 in BC, particularly in the ER-negative histotypes, [12,13,14,15,21], whereas only few controversial studies have attempted to clarify the role of S100A7 in ER-positive breast tumors [16,17,18]. This evidence concerns the gene S100A7 and breast cancer.